IFNA2 and incontinentia pigmenti: During the COVID-19 pandemic, it was suggested that the patients with the IKBKG mutation typical for IP (IKBKG 4–10 exon deletion) have a higher frequency of the presence of autoantibodies IFN-α2a and IFN-ω [26].